Kathy

I love #coffee and #cats, am a Bipolar, PAH and RA Warrior too

[Manifest_Lord @Manifest_Lord]

The point is called Nei Guan.

It sits on the inner wrist.

Three finger widths below the wrist crease.

Between the two tendons you can feel when you press gently.

You have had it your entire life. Nobody told you what it does.

[Kathy @KatyaPace]

Knee osteoarthritis: Could surgery actually worsen it? https://t.co/HRMxmZGUKi via @mnt

[Kathy @KatyaPace]

How a discovery in joint fluid could change the way we treat arthritis https://t.co/FyZgqGShS1 via @mnt

[Kathy @KatyaPace]

https://t.co/7ZRpC0FsTe

[Kathy @KatyaPace]

Dementia Risk May Be Linked to One's Outlook, Study Suggests https://t.co/Mv49DyfwTW

[Kathy @KatyaPace]

@Matt_Pinner Dotty

[Kathy @KatyaPace]

Expert Q&A: Can lithium help slow memory decline? https://t.co/a9NvNBfN5C via @mnt

[Kathy @KatyaPace]

Expert Q&A: Can lithium help slow memory decline? https://t.co/a9NvNBfN5C via @mnt

[Kathy @KatyaPace]

New Nomogram Can Predict PAH Prognosis in a Noninvasive Manner https://t.co/pU6bxu0Ij9

[Kathy @KatyaPace]

Treatment of Incident PAH Deviates From Current Guideline-Recommended Care https://t.co/lrW1YXZaxo

[Kathy @KatyaPace]

A TriNetX real-world analysis suggests Winrevair may improve survival in people with PAH and reduce the need for lung transplant. https://t.co/2L5OKtIUS7

[Metabolic Factor @MetabolicFactor]

The brain cleans itself during sleep. 🧠💤

📹: xavork

[Kathy @KatyaPace]

Aurora Australis Expected to Dazzle Again Tonight Amid G4 Solar Storm https://t.co/njyAd25gkV via @SSBCrack

[Kathy @KatyaPace]

Pulmonary arterial hypertension (PAH) is a rare disease that affects the lungs and can lead to serious complications. There are four types of PAH, and whil https://t.co/6M0IFs8hCI

[Kathy @KatyaPace]

https://t.co/Gh9DTKNG0J

[Kathy @KatyaPace]

Early diagnosis of pulmonary arterial hypertension improves five-year survival by 42%, compared with delayed diagnosis, a study shows. https://t.co/1FLbJAMs9I

[Kathy @KatyaPace]

Jagged-2, a signaling protein, may be a potential therapeutic target for slowing or halting the progression of PAH, according to a rat study. https://t.co/KNRMGEBjHh

[Kathy @KatyaPace]

https://t.co/FzlsXNdFwA

[Kathy @KatyaPace]

Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH) https://t.co/0Re1HIRi1c via @MFN_IRnews

[Kathy @KatyaPace]

https://t.co/PDpHqh5A3x